Integrative clinical genomics of advanced prostate cancer.
about
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerGaleterone for the treatment of advanced prostate cancer: the evidence to dateCYP17 inhibitors in prostate cancer: latest evidence and clinical potentialAdvances in genetics: widening our understanding of prostate cancerAberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles BiogenesisControl of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in CancerResistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate CancerClonal origin and spread of metastatic prostate cancerTranslating cancer genomes and transcriptomes for precision oncologyPersistent androgen receptor addiction in castration-resistant prostate cancerEmerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerStem cells in genetically-engineered mouse models of prostate cancerAndrogen receptor and prostate cancer stem cells: biological mechanisms and clinical implicationsWhat is the Need for Prostatic Biomarkers in Prostate Cancer Management?Next-generation sequencing to guide cancer therapyMutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide TherapyCIViC databaseDNA-Repair Defects and Olaparib in Metastatic Prostate CancerNovel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate CancerUse of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinicTargeting intratumoral androgens: statins and beyondIs it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate CancerMetastatic colonization by circulating tumour cellsEmerging data on androgen receptor splice variants in prostate cancerResistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expressionComprehensive Molecular Portraits of Invasive Lobular Breast CancerN-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerTrial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Antagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancerThe Promyelocytic Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal Cell Decidualization.Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.DNA copy number changes define spatial patterns of heterogeneity in colorectal cancer.METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.Use of big data in drug development for precision medicine.Knockdown of AKR1C3 exposes a potential epigenetic susceptibility in prostate cancer cellsTET2 binds the androgen receptor and loss is associated with prostate cancer.Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancerIntersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers.Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer.
P2860
Q26739708-9D26690A-D31A-4D8B-85F5-4B8AA822BA95Q26739887-8A4F52ED-4066-4D05-8448-6B8CE3E28953Q26740070-6D18A6AC-6F72-466A-AFD6-DD85CEDA8D75Q26740628-C8F0AC31-D65C-403F-8124-E142D662DE5FQ26744233-9BFF0BE3-61B4-4ED9-9420-9F21FDB68773Q26747432-DB892143-5031-430F-AFB3-14333AA497DAQ26751237-24E528B7-1EF8-4EA2-BB52-AAECE4AE6C7EQ26752873-385D98E1-03FF-4C6B-A355-7170DBCEB21BQ26777081-53DFB51A-90D3-47D1-BD1B-EE480F713C8EQ26777163-D1654D20-0EEA-4143-8FF0-8E2AF599FE64Q26777310-0FD75025-B7FF-4E47-B867-7516D2550587Q26784057-36458CFC-7F2C-410F-AC63-81A3E3C176A0Q26797063-892E6C3F-B0B4-4820-8D14-61DAB4B9D25DQ26798425-92882F3D-A32A-41B4-A743-2B1CFDBDCDE0Q26801946-0957CBF0-2FBB-4A75-9C3A-818FD1C91487Q27334558-72014411-ECF7-4629-84D5-941D2DFE0795Q27612411-3833DAFC-EBFB-4DA6-95F8-3FC91C91F660Q27853235-6DDE4298-180B-4F35-B80C-1F1C2F087F64Q28067556-E9091C2E-89A0-40AC-B76C-D859A9FC0A39Q28071541-80E5FA18-E1AC-413C-AF19-C2BA70482189Q28073619-4C76797A-DA27-4958-AA40-983E2C729832Q28073673-A90F5005-A31E-4283-B143-08825BEC758AQ28075965-F5757A6A-FE8A-4AFC-B44B-BA6E1CE9E9F0Q28076164-B52E0104-A88C-4D64-A58C-819885490B45Q28077830-59E22ACB-3CF8-4108-9A54-543075A06FBDQ28117805-4AC1718E-9F5A-4EAD-9B0C-07DF4200AC14Q28268284-F83FE967-B75B-4D5C-BE9F-6E29A429C5C3Q28771715-E1B18068-F984-4990-B630-FDAFD948D5A4Q30277291-DCB04859-3BA5-419F-9B09-BBCB55130B4AQ30360857-7A5832E8-F247-436F-9509-B45252009B09Q30385625-6855F113-B776-4EB9-BFAA-77B49A502B74Q30831010-D22092FD-9E80-4BBA-8C4F-40130D4E17C5Q30837199-F4146EF9-279C-4F30-B346-9D07008BE839Q31108842-9DCD1128-0EF6-4919-A25C-0C9CDBD20601Q31115480-A8E50D86-F953-4EA6-B22C-8773A8C25207Q33563699-70E16C19-0543-4F35-A6E1-CF22B6390DE0Q33563729-3B34A6C8-3A7B-49BF-B527-C0C4F73216EAQ33571906-A5539830-86F3-42D1-A3D6-F319085C097BQ33572945-605D5225-3751-4A12-9E3D-B0911C677A04Q33622362-9E8479F9-238D-4D8A-AF58-240F8E5F7785
P2860
Integrative clinical genomics of advanced prostate cancer.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Integrative clinical genomics of advanced prostate cancer.
@ast
Integrative clinical genomics of advanced prostate cancer.
@en
Integrative clinical genomics of advanced prostate cancer.
@nl
type
label
Integrative clinical genomics of advanced prostate cancer.
@ast
Integrative clinical genomics of advanced prostate cancer.
@en
Integrative clinical genomics of advanced prostate cancer.
@nl
altLabel
Integrative Clinical Genomics of Advanced Prostate Cancer
@en
prefLabel
Integrative clinical genomics of advanced prostate cancer.
@ast
Integrative clinical genomics of advanced prostate cancer.
@en
Integrative clinical genomics of advanced prostate cancer.
@nl
P2093
P2860
P50
P3181
P1433
P1476
Integrative clinical genomics of advanced prostate cancer.
@en
P2093
Alexandros Sigaras
Andrea Sboner
Anuradha Gopalan
Arul M Chinnaiyan
Brian D Robinson
Bruce Montgomery
Charles L Sawyers
Christine Brennan
Colin C Pritchard
Dan Robinson
P2860
P304
P3181
P356
10.1016/J.CELL.2015.05.001
P407
P50
P577
2015-05-21T00:00:00Z